Intelligence Profile
Clinical Applications
VEGF (Vascular Endothelial Growth Factor) plasmids are utilized in various clinical contexts primarily focused on promoting angiogenesis, which is the formation of new blood vessels. This therapeutic approach aims to improve blood flow and tissue healing in several conditions.
Osteoporosis Therapy: A study published in the International Journal of Pharmaceutics discusses the use of bone-targeted delivery of VEGF and BMP2 plasmids for treating osteoporosis. The delivery via nanoparticles suggests potential benefits in promoting bone regeneration and enhancing bone density through angiogenesis and osteogenesis.
Lower Extremity Ischemia: According to a paper in Cells, VEGF gene therapy has made experimental and clinical advances in treating lower extremity ischemia. This condition, characterized by reduced blood flow to the extremities, may benefit from enhanced vascular growth induced by VEGF plasmid delivery.
Intermittent Claudication: The clinical trial NCT00080392 explores the use of EW-A-401, a VEGF-based therapy, for intermittent claudication—a condition causing pain due to inadequate blood flow during exercise. The phase 1 trial has been completed, suggesting initial investigations into safety and efficacy.
No-option Coronary Artery Disease (CAD): The trial NCT00620217 investigated VEGF-A165/bFGF plasmids in patients with no available options for traditional revascularization therapies. This phase 2 trial indicates a controlled exploration of VEGF/bFGF plasmid efficiency in inducing angiogenesis to potentially restore blood supply to the heart.
Bone Regeneration: VEGF plasmids have also been studied in the context of bone regeneration. Trials such as NCT06365307 and NCT03076138 examined the use of gene-activated bone substitutes in spinal and maxillofacial bone regeneration, respectively, highlighting their potential in surgical orthopedic applications.
The evidence supports various experimental and early-phase clinical applications of VEGF plasmids in enhancing angiogenesis and tissue repair, though further research is necessary to establish broader efficacy and safety for routine clinical use.
Disclaimer: This content is for informational purposes only and not intended as medical advice. Please consult a healthcare professional for personalized medical guidance.